Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EyePoint
AddedFeb 19, 2024
UpdatedJul 4, 2026
EyePoint

EyePoint

Public

EyePoint Pharmaceuticals, a global biopharmaceutical firm, develops drug devices for chronic eye disorders.

HQ
Watertown, MA, US
Founded
2008
Overview
Compare
Fundraising
Employees

EyePoint Pharmaceuticals, based in Watertown Town, Massachusetts, is a global biopharmaceutical company focused on developing drug devices to treat chronic eye disorders and other debilitating conditions. The company aims to improve patient outcomes through innovative treatments and serves customers worldwide.

EyePoint Pharmaceuticals has made significant strides in the biopharmaceutical industry, contributing to advancements in ocular drug delivery systems. The company's impact is evident in its global reach and the improved quality of life for patients with chronic eye conditions.

EyePoint - Similar Companies

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

Eye-Pharma logo

Eye-Pharma

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Visiox logo

Visiox

visioxpharma.com

EyeCyte logo

EyeCyte

eyecyte.com

Ocuphire Pharma logo

Ocuphire Pharma

ocuphire.com

Ocular Science logo

Ocular Science

ocularscience.com

MediPrint Ophthalmics logo

MediPrint Ophthalmics

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Alimera Sciences logo

Alimera Sciences

TearClear logo

TearClear

tearclear.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

OcuCure Therapeutics logo

OcuCure Therapeutics

EyePoint - Quick Facts

Who are EyePoint's competitors?

Companies similar to EyePoint include Hyperion DeFi, Eye-Pharma, Ocular Therapeutix and Surface Pharmaceuticals.

When was EyePoint founded?

EyePoint was founded in 2008.

Where is EyePoint's headquarters located?

EyePoint's headquarters is located in Watertown, MA, US.

When was EyePoint's last funding round?

EyePoint's most recent funding round was for $215.9M (USD) in December 2023.

How much has EyePoint raised to-date?

As of Dec 5, 2023, EyePoint has raised a total of $653.8M (USD).

How many employees does EyePoint have?

EyePoint has 144 employees as of Feb 6, 2024.

EyePoint - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Drug Devices
Tags
  • Healthtech
Unique IDs
  • secCik: 0001314102
  • ticker: EYPT
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research